These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12046391)

  • 1. [Antibiotic use and toxicity in liver diseases].
    Siutkin VE; Ivanikov IO
    Eksp Klin Gastroenterol; 2002; (2):65-7. PubMed ID: 12046391
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
    Fung WP
    Drugs; 1974; 8(2):139-45. PubMed ID: 4434868
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifaximin treatment in hepatic encephalopathy.
    Wang CC; Kao JH
    N Engl J Med; 2010 Jun; 362(25):2423; author reply 2424-5. PubMed ID: 20573932
    [No Abstract]   [Full Text] [Related]  

  • 4. A pill a day can improve survival in patients with advanced cirrhosis.
    Runyon BA
    Gastroenterology; 2007 Sep; 133(3):1029-31. PubMed ID: 17854604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic diseases].
    Yamamoto S
    Naika; 1969 Jan; 23(1):11-7. PubMed ID: 4888164
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of liver disease with corticosteroids.
    Lesesne HR; Fallon HJ
    Med Clin North Am; 1973 Sep; 57(5):1191-201. PubMed ID: 4593197
    [No Abstract]   [Full Text] [Related]  

  • 7. Metronidazole-induced encephalopathy in a patient with liver cirrhosis.
    Cheong HC; Jeong TG; Cho YB; Yang BJ; Kim TH; Kim HC; Cho EY
    Korean J Hepatol; 2011 Jun; 17(2):157-60. PubMed ID: 21757988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous bacterial peritonitis- undervalued complication in liver cirrhosis].
    Prelipcean CC
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):682-4. PubMed ID: 12092220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin-induced acute cholestatic hepatitis in a patient with alcoholic liver cirrhosis.
    Romero-Gómez M; Suárez García E; Fernández MC
    Am J Gastroenterol; 1999 Aug; 94(8):2324-5. PubMed ID: 10445586
    [No Abstract]   [Full Text] [Related]  

  • 10. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy].
    MMW Fortschr Med; 2014 Feb; 156(3):64-5. PubMed ID: 24938070
    [No Abstract]   [Full Text] [Related]  

  • 14. Durability of rifaximin response in hepatic encephalopathy.
    Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N
    J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary prophylaxis of spontaneous bacterial peritonitis].
    Soriano G; Guarner C
    Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 17. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S; Sharma A; Bhatt G
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current problems in the prevention and treatment of infections in patients with cirrhosis].
    Bellot P; Jara Pérez López N; Martínez Moreno B; Such J
    Gastroenterol Hepatol; 2010 Dec; 33(10):729-40. PubMed ID: 20444525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the therapeutic effect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patients with spontaneous bacterial peritonitis.
    Rastegar LA; Umrani G; Dehbashi N; Malec F
    Hepatogastroenterology; 1998; 45(21):783-5. PubMed ID: 9684134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.